![Sartorius Aktiengesellschaft Website](https://cdn.finchat.io/881470.png)
Sartorius Aktiengesellschaft
XTRA-SRT3
Company Overview
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Name
Sartorius Aktiengesellschaft
CEO
Dr. Joachim Kreuzburg
Website
www.sartorius.com
Sector
Life Sciences Tools and Services
Year Founded
1870
Profile
Market Cap
€14.6B
EV
€19.73B
Shares Out
69.04M
Revenue
€3,340.8M
Employees
14,143
Margins
Gross
45.27%
EBITDA
23.34%
Operating
13.95%
Pre-Tax
5.65%
Net
2.33%
FCF
10.48%
Returns (5Yr Avg)
ROA
5.99%
ROTA
41.6%
ROE
18.26%
ROCE
17.37%
ROIC
11.14%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
€267.5
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
€591.2M
Net Debt
€4,032.5M
Debt/Equity
1.21
EBIT/Interest
2.36
Growth (CAGR)
Rev 3Yr
4.73%
Rev 5Yr
14.44%
Rev 10Yr
15.76%
Dil EPS 3Yr
-0.78%
Dil EPS 5Yr
7.73%
Dil EPS 10Yr
14.58%
Rev Fwd 2Yr
4.37%
EBITDA Fwd 2Yr
6.35%
EPS Fwd 2Yr
8.95%
EPS LT Growth Est
17.5%
Dividends
Yield
—
Payout
65.5%
DPS
€0.74
DPS Growth 3Yr
1.87%
DPS Growth 5Yr
3.94%
DPS Growth 10Yr
11.46%
DPS Growth Fwd 2Yr
11.97%